Toward the harmonization of immune monitoring in clinical trials: Quo vadis? C. M. BrittenS. JanetzkiA. Hoos Commentary Open access 25 August 2007 Pages: 285 - 288
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays C. M. BrittenC. GouttefangeasS. H. van der Burg Original Article Open access 25 August 2007 Pages: 289 - 302
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI) Sylvia JanetzkiKatherine S. Panageasfor the Elispot Proficiency Panel of the CVC Immune Assay Working Group Original Article Open access 25 August 2007 Pages: 303 - 315
Plant-derived EpCAM antigen induces protective anti-cancer response Robert BrodzikSergei SpitsinHilary Koprowski Original Article 19 July 2007 Pages: 317 - 323
Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression Heriberto Prado-GarciaDolores Aguilar-CazaresJose Sullivan Lopez-Gonzalez Original Article 01 August 2007 Pages: 325 - 336
Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer Tetsuro UchidaShigetoshi HoriguchiYoshitaka Okamoto Original Article 10 August 2007 Pages: 337 - 345
Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells Elizabeth P. RyanTimothy P. BushnellRichard P. Phipps Original Article 01 August 2007 Pages: 347 - 358
Potential contribution of naïve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion Antonia TeruelMarcela RomeroAnahid Jewett Original Article 17 August 2007 Pages: 359 - 366
Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning Qing-An YuanMatthew K. RobinsonGregory P. Adams Original Article 04 August 2007 Pages: 367 - 378
Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity Maria LiljeforsBo NilssonJan-Erik Frödin Original Article 04 August 2007 Pages: 379 - 388
The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes James A. ThompsonMinu K. SrivastavaSuzanne Ostrand-Rosenberg Original Article 28 August 2007 Pages: 389 - 398
CD8+ T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients Sofia VikmanValeria GiandomenicoThomas H. Tötterman Original Article 24 August 2007 Pages: 399 - 409
Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells Tina MüllerChristoph UherekWinfried S. Wels Original Article 24 August 2007 Pages: 411 - 423
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics Natalie KronikYuri KoganZvia Agur Original Article 07 September 2007 Pages: 425 - 439
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics Natalie KronikYuri KoganZvia Agur Erratum 07 December 2007 Pages: 441 - 441